UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$1.02M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$492.02
Sep 2, 2026
Close before public filing
$492.02
Sep 2, 2026
Return since public filing
+1.03%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,067 shares @ $492.25
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000134
Filing cohort
Transactions in this filing
Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.97M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 2, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $57.32K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $76.62K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $76.78K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $38.61K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $58.21K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $77.81K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $117.37K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $274.51K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $900.7K |
| United Therapeutics Corp UTHR Current | Sale | Sep 2, 2026 | $1.02M |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $256.67K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $257.05K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $209.79K |
| United Therapeutics Corp UTHR | Sale | Sep 2, 2026 | $386.13K |